Evidence map›Paper›PMID 41877619›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Affective neuropsychiatric symptom metrics in the National Alzheimer's Coordinating Center dataset.

Daniel W Fisher, Ronak Mehta, Christopher B Morrow, Kathleen F Kerr, Suman Jayadev, Kimiko Domoto-Reilly, Michael J Schrift, Martin Darvas

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clinical Associations and Possible Risk Factors for Affective Neuropsychiatric Symptoms in Older Adults With and Without Cognitive Impairment.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Daniel W FisherDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0003-3271-8327
Ronak MehtaDepartment of Statistics, University of Washington, Seattle, WA, USA.
Christopher B MorrowDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-4600-1802
Kathleen F KerrDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Suman JayadevDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0003-3164-9665
Kimiko Domoto-ReillyDepartment of Neurology, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0002-7396-1633
Michael J SchriftDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0009-0003-7162-6844
Martin DarvasDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0002-7942-2526

Funding

National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
A geroscience approach for treating Alzheimer's diseaseR01AG067193 · NIA · UNIVERSITY OF WASHINGTON · PI DARVAS, MARTIN C, LADIGES, WARREN C · 2020 to 2024
$4.4M
Modulation of Alzheimers disease by Herpes simplex virus infection R01AG062514 · NIA · UNIVERSITY OF WASHINGTON · PI DARVAS, MARTIN C, FUNK, CORY · 2019 to 2023
$2.7M
Serotonin Modulation of Neural Circuitry in bvFTD: Understanding the Neurobiology of Mood and Cognitive SymptomsK23AG088248 · NIA · JOHNS HOPKINS UNIVERSITY · PI Christopher B. Morrow · 2024 to 2026
$594k
NIA NIH HHS K23 AG088248NIA NIH HHS R01 AG062514NIA NIH HHS R01 AG067193NIA NIH HHS T32 AG052354NIA NIH HHS U24 AG072122
6 · The paper itself

Abstract

BackgroundIn dementia research, affective neuropsychiatric symptoms (NPS)-depression, anxiety, and apathy-remain understudied. Improving strategies to ensure robust and comparable identification of clinically relevant NPS is essential for better research.ObjectiveWe sought to determine how often objective metrics and clinical gestalt metrics agree on NPS presence or absence. We further sought to determine optimal cut-offs for affective NPS presence/absence using the Neuropsychiatric Inventory Questionnaire (NPIQ) severity ratings.MethodsWe assessed agreement for NPS presence/absence among 5 different depression metrics, 4 anxiety metrics, and 2 apathy metrics via Jaccard indices using the National Alzheimer's Coordinating Center (NACC) dataset. Analysis included exploring four different NPIQ severity rating thresholds of ">0", ">1", ">2", and "=0 and >1".ResultsNPIQ cut-off >1 for presence and =0 for absence of an NPS led to the best agreement with other metrics. However, there was poor agreement for NPS presence across depression metrics (6%) and across anxiety metrics (7%). Choice of metric could greatly skew the frequency of an NPS being present. All 3 affective NPS were more common in Lewy body disorder compared to Alzheimer's disease or vascular cognitive impairment, regardless of metric.ConclusionsThough NPIQ severity rating cut-off choice should depend on study design, using a severity score of >1 for presence and =0 for absence may best fit clinical gestalt for affective NPS. Lewy body disorders present with more affective NPS than other common dementia etiologies. Future consensus on criteria for depression and anxiety syndromes in dementia may improve their identification.

Indexed as

Alzheimer DiseaseAnxietyDepressionAgedApathyFemaleHumansMaleNeuropsychological TestsPsychiatric Status Rating ScalesSeverity of Illness IndexUnited StatesAlzheimer's diseasebehavioral and psychological symptoms of dementiadementiafrontotemporal dementiaLewy body dementiaNational Alzheimer's Coordinating Centerneurodegenerationneuropsychiatric inventoryneuropsychiatric symptomsvascular cognitive impairment

Identifiers

PMID41877619
PMCPMC13242860

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.